Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 16 of the 54 sources its claims cite were checked for support.
Abstract
Euglycemic hyperinsulinemia evokes both sympathetic activation and vasodilation in skeletal muscle, but the mechanism remains unknown. To determine whether insulin per se or insulin-induced stimulation of carbohydrate metabolism is the main excitatory stimulus, we performed, in six healthy lean subjects, simultaneous microneurographic recordings of muscle sympathetic nerve activity, plethysmographic measurements of calf blood flow, and calorimetric determinations of carbohydrate oxidation rate. Measurements were made during 2 h of: (a) insulin/glucose infusion (hyperinsulinemic [6 pmol/kg per min] euglycemic clamp), (b) exogenous glucose infusion at a rate matched to that attained during protocol a, and (c) exogenous fructose infusion at the same rate as for glucose infusion in protocol b. For a comparable rise in carbohydrate oxidation, insulin/glucose infusion that resulted in twofold greater increases in plasma insulin concentrations than did glucose infusion alone, evoked twofold greater increases in both muscle sympathetic nerve activity and calf blood flow. Fructose infusion, which increased carbohydrate oxidation comparably, but had only a minor effect on insulinemia, did not stimulate either muscle sympathetic nerve activity or calf blood flow. These observations suggest that in humans hyperinsulinemia per se, rather than insulin-induced stimulation of carbohydrate metabolism, is the main mechanism that triggers both sympathetic activation and vasodilation in skeletal muscle.
Overview
CoChat Summary
TL;DR
In healthy lean humans, euglycemic hyperinsulinemia increased muscle sympathetic nerve activity (MSNA) and calf blood flow more than glucose infusion alone despite comparable carbohydrate oxidation, while fructose infusion increased carbohydrate oxidation without stimulating MSNA or calf blood flow. The authors conclude that hyperinsulinemia per se, rather than insulin-induced carbohydrate metabolism, is the main trigger for sympathetic activation and skeletal-muscle vasodilation.
Key findings
- During 2-h insulin/glucose infusion, plasma insulin rose to 376.2±30.0 pmol/liter and increased MSNA burst frequency by 93±18%, calf blood flow by 47±14%, and decreased calf vascular resistance by 19±4%.
- Glucose infusion alone produced comparable carbohydrate oxidation but a smaller insulin rise (282.6±19.8 pmol/liter) and about half the responses: MSNA burst frequency increased 54±10% and calf blood flow 20±6%.
- Fructose infusion increased carbohydrate oxidation even more than insulin/glucose or glucose infusion (23±2 vs 21±1 and 20±1 μmol/kg per min at 90–120 min) but caused only a minor insulin rise (37.2±1.9 to 57.0±2.7 pmol/liter) and had no effect on MSNA, calf blood flow, or calf vascular resistance.
- MSNA and calf blood flow rose significantly at 45 min during insulin/glucose infusion but only at 90 min during glucose infusion; during fructose infusion, glucose oxidation increased by 22±7%.
Methods
- Six lean, healthy subjects (weight 70.8±4.3 kg, BMI 21.8±0.8 kg/m², age 28±4 yr) underwent 2-h protocols: hyperinsulinemic euglycemic clamp (insulin 6 pmol/kg per min), exogenous glucose infusion matched to the clamp, and fructose infusion matched to glucose; five of six subjects completed fructose infusion.
- Simultaneous measurements included microneurographic MSNA recordings from the peroneal nerve, venous occlusion plethysmography for calf blood flow, indirect calorimetry for carbohydrate oxidation, and plasma hormone/substrate assays.
- A fourth protocol in six lean healthy male subjects (age 30±4 yr, BMI 22.9±0.6 kg/m²) used [U-¹³C]glucose infusion and breath ¹³CO₂/plasma [¹³C]glucose enrichment to measure glucose oxidation during fructose infusion.
- Statistical analysis used repeated-measures ANOVA, paired t tests with Bonferroni adjustment, and least-squares correlations; P<0.05 was significant.
Limitations
- The paper states that indirect calorimetry cannot differentiate glucose from fructose oxidation, that nonoxidative glucose disposal calculations were not performed during fructose infusion because endogenous glucose production was not measured and is not suppressed, and that total carbohydrate uptake may have been slightly higher during fructose infusion.
- The paper states that the experiments do not elucidate the underlying mechanisms of insulin-induced sympathetic activation and vasodilation, and that MSNA recordings were targeted specifically at skeletal muscle, so fructose-induced sympathetic outflow to other tissues such as liver cannot be excluded.
- Evident from the text: the main protocols included only six lean healthy subjects (five for fructose), limiting generalizability; the fourth protocol included only male subjects, and the study did not measure interstitial insulin directly.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 0 Not valid · 16 Not checked · 51 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“First, there is increasing evidence that stimulation of blood flow to insulin-sensitive tissues during insulin/glucose and glucose infusion may be an important determinant of the rate of in vivo glucose uptake (10, 11, 38).”
What the sources say
- Not matchedcites [10] 10. Laakso, M., S. V. Edelman, J. M. Olefsky, G. Brechtel, P. Wallace, and A. D. Baron. 1990. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 39:965-974.
More than one paper fits this citation.
- Partly supportedcites [11] 11. Laakso, M., S. V. Edelman, G. Brechtel, and A. D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 85:1844–1852. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says increased blood flow is closely linked to glucose uptake and may contribute particularly after two hours of hyperinsulinemia. The Protocol describes insulin infusion with glucose clamped at euglycemia, but the paper does not establish the same point for glucose infusion without insulin. Its findings also concern skeletal muscle rather than insulin-sensitive tissues generally. (LLM, conf=0.85)
- Not matchedcites [38] 38. Edelman, S. V., M. Laakso, P. Wallace, G. Brechtel, J. M. Olefsky, and A. D. Baron. 1990. Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes. 39:955–964.
More than one paper fits this citation.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“as recent evidence indicates that insulin resistance is associated with attenuated hyperinsulinemia-induced vasodilation in skeletal muscle (10, 11).”
What the sources say
- Not matchedcites [10] 10. Laakso, M., S. V. Edelman, J. M. Olefsky, G. Brechtel, P. Wallace, and A. D. Baron. 1990. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 39:965-974.
More than one paper fits this citation.
- Supportedcites [11] 11. Laakso, M., S. V. Edelman, G. Brechtel, and A. D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 85:1844–1852. source
The Discussion reports that insulin’s effect on skeletal-muscle blood flow is impaired in obese men and that this defect could be associated with in vivo insulin resistance. Its summary also describes a right-shifted blood-flow response to insulin in obese versus lean subjects. The finding is established for the men studied; extension to other insulin-resistant states is presented as a possibility. (LLM, conf=0.91)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, the conclusions of one study were based upon the absence of a detectable effect of glucose infusion on plasma norepinephrine levels (5, 26), a relatively insensitive index of sympathetic discharge (34–36).”
What the sources say
- Partly supportedcites [5] 5. Berne, C., J. Fagius, and F. Niklasson. 1989. Sympathetic response to oral carbohydrate administration. J. Clin. Invest. 84:1403-1409. sourceExperimental — accuracy not yet measured
The Sympathetic activity results report minor or no plasma norepinephrine change after intravenous glucose. But the Discussion bases its conclusion that intravenous glucose did not increase sympathetic activity on direct microelectrode recordings of muscle sympathetic activity, using the norepinephrine results as corroboration—not as the sole basis for the conclusion. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [26] 26. Rowe, J. W., J. B. Young. K. L. Minaker, A. L. Stevens, J. Pallota, and L. Landsberg. 1981. Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219–225. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Second, a balance between insulin's opposing sympathoexcitatory pressor and vasodilatory depressor effects may offer a potential explanation for the present, and earlier (6, 7, 26) observations, that in lean healthy subjects acute hyperinsulinemia at high physiologic concentrations does not raise arterial pressure.”
What the sources say
- Partly supportedcites [6] 6. Anderson, E. A., R. P. Hoffman, T. W. Balon, C. A. Sinkey, and A. L. Mark. 1991. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87:2246–2252. sourceExperimental — accuracy not yet measured
The Discussion says that sympathetic pressor and vasodilatory depressor actions appear relatively balanced during acute insulin increases in the physiologic postprandial range, so arterial pressure does not rise. The Subjects section describes healthy males, but their BMI ranged from 21 to 32; the paper does not establish the finding specifically for lean subjects. (LLM, conf=0.82)
- Supportedcites [7] 7. Berne, C., J. Fagius, T. Pollare, and P. Hjemdahl. 1992. The sympathetic response to euglycaemic hyperinsulinaemia: evidence from microelectrode nerve recordings in healthy subjects. Diabetologia. 35:873–879. source
In the Discussion (page not available in our copy), the authors report that insulin increased muscle sympathetic activity at a high physiological concentration and suggest that this response helps maintain blood pressure despite insulin’s vasodilatory effects. The Abstract reports that blood pressure was not notably affected in the healthy subjects studied. This supports the proposed balance as a possible explanation, rather than an established mechanism. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [26] 26. Rowe, J. W., J. B. Young. K. L. Minaker, A. L. Stevens, J. Pallota, and L. Landsberg. 1981. Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219–225. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During fructose infusion, plasma glucose concentrations remained stable, whereas plasma fructose concentrations rose from undetectable levels to 2.0±0.2 mmol/liter by the end of the first hour of infusion, and remained unchanged thereafter (Table I).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 78 claims and to verify the 5 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In our laboratory, the intraobserver and interobserver coefficients of variation of the mean in identifying bursts are < 6% and < 9%, respectively (14).”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, MS components such as visceral obesity, peripheral insulin resistance, and reactive hyperinsulinemia have been found to result in sympathetic hyperactivity.[5][6][7]”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lean subjects, sympathetic activation evoked by acute elevation of plasma insulin to high physiological concentrations does not raise blood pressure (12–14)”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“In lean healthy subjects, insulin-induced stimulation of muscle blood flow consistently is accompanied by a marked stimulation of sympathetic neural outflow to the same vascular bed (12-14).”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
In the citing paper
“Sympathetic activation has already been associated with many of the individual components of the MS, such as visceral obesity, 5 insulinemia, 6 EHT, [1][2][3][4] and type 2 diabetes.7”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Nonoxidative glucose disposal (pmol/kg per min) | - | 21±4 | 22±8 | - | 6±1t”
Reported 6 · recomputed 12
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 3
“had no effect on MSNA, calf blood flow, or calf vascular resistance”
§ Analytical methods · p. 3
“| Calf vascular resistance (Units) | 43.3±1.3 | 34.3±1.6* | 32.8±2.0* | 45.6±2.2 | 42.9±2.7* | 40.5±3.2* | 49.7±5.3 | 49.0±5.7t | 45.7±5.2* |”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Coated Charcoal Immunoassay of Insulin
HERBERT, V., LAU, K.-S., GOTTLIEB, C. W., & BLEICHER, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,968
Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves
Vallbo, A. B., Hagbarth, K. E., Torebjork, H. E., & Wallin, B. G. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.4.919 · Cited by 1,507
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
Schuler, G., Hambrecht, R., Schlierf, G., Niebauer, J., Hauer, K., Neumann, J., Hoberg, E., Drinkmann, A., Bacher, F., & Grunze, M. (1992) · Circulation · doi:10.1161/01.cir.86.1.1 · Cited by 1,340
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Hawk’s Physiological Chemistry
Prosky, L. (1966) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/49.2.477 · Cited by 1,047
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Parati, G., Casadei, R., Groppelli, A., Di Rienzo, M., & Mancia, G. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.647 · Cited by 899
Hawk's physiological chemistry
HAWK, P. B., & Oser, B. L. (1965) · Medical Entomology and Zoology · Cited by 871
Cited by
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Tappy, L., & Lê, K.-A. (2010) · Physiological Reviews · doi:10.1152/physrev.00019.2009 · Cited by 1,256
Self-citationSteinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N., & Baron, A. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,223
“In a recent report, Vollenweider and co-workers (8) attempted to separate the role of hyperinsulinemia per se and hyperinsulinemia-induced carbohydrate metabolism in the regulation of skeletal muscle blood flow.”
BackgroundSeravalle, G., & Grassi, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.013 · Cited by 909
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Nitric oxide release accounts for insulin's vascular effects in humans.
Scherrer, U., Randin, D., Vollenweider, P., Vollenweider, L., & Nicod, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117621 · Cited by 756
“a variable infusion of 20% dextrose (5).”
BackgroundMethodInfluentialSelf-citationThermogenic Mechanisms and Their Hormonal Regulation
Silva, J. E. (2006) · Physiological Reviews · doi:10.1152/physrev.00009.2005 · Cited by 687
“Whether the increased sympathetic activity to the muscle per se increases glucose oxidation is not clear (245).”
BackgroundHemodynamic actions of insulin
Baron, A. D. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.2.e187 · Cited by 608
Stein, J. H., Keevil, J. G., Wiebe, D. A., Aeschlimann, S., & Folts, J. D. (1999) · Circulation · doi:10.1161/01.cir.100.10.1050 · Cited by 578
Mahfoud, F., Schlaich, M., Kindermann, I., Ukena, C., Cremers, B., Brandt, M. C., Hoppe, U. C., Vonend, O., Rump, L. C., Sobotka, P. A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.991869 · Cited by 573
Mechanisms of Sympathetic Activation in Obesity-Related Hypertension
Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., & Lambert, E. (2006) · Hypertension · doi:10.1161/01.hyp.0000242642.42177.49 · Cited by 443
Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
Thorp, A. A., & Schlaich, M. P. (2015) · Journal of Diabetes Research · doi:10.1155/2015/341583 · Cited by 425
Regional Sympathetic Nervous Activity and Oxygen Consumption in Obese Normotensive Human Subjects
Vaz, M., Jennings, G., Turner, A., Cox, H., Lambert, G., & Esler, M. (1997) · Circulation · doi:10.1161/01.cir.96.10.3423 · Cited by 404
Neural mechanisms in human obesity-related hypertension
Rumantir, M. S., Vaz, M., Jennings, G. L., Collier, G., Kaye, D. M., Seals, D. R., Wiesner, G. H., Brunner-La Rocca, H. P., & Esler, M. D. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917080-00012 · Cited by 396
Body fat and sympathetic nerve activity in healthy subjects.
Scherrer, U., Randin, D., Tappy, L., Vollenweider, P., Jéquier, E., & Nicod, P. (1994) · Circulation · doi:10.1161/01.cir.89.6.2634 · Cited by 383
Self-citationScherrer, U., & Sartori, C. (1997) · Circulation · doi:10.1161/01.cir.96.11.4104 · Cited by 371
Self-citationBlood flow and muscle metabolism: a focus on insulin action
Clark, M. G., Wallis, M. G., Barrett, E. J., Vincent, M. A., Richards, S. M., Clerk, L. H., & Rattigan, S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00408.2002 · Cited by 359
“This is possibly due to the opposing effects of increased sympathetic vasoconstrictor action and a decrease in skeletal muscle vascular resistance (190).”
BackgroundMethodInfluentialLambert, G. W., Straznicky, N. E., Lambert, E. A., Dixon, J. B., & Schlaich, M. P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.002 · Cited by 347
Vascular function, insulin resistance and fatty acids
Steinberg, H., & Baron, A. (2002) · Diabetologia · doi:10.1007/s00125-002-0800-2 · Cited by 341
“A number of studies by a variety of techniques have now confirmed the NO dependency of insulin-mediated vasodilation in other vascular beds such as the forearm [13, 38, 39], supporting the notion that this effect is probably generalised in insulin sensitive tissues.”
BackgroundInsulin: The master regulator of glucose metabolism
Norton, L., Shannon, C., Gastaldelli, A., & DeFronzo, R. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155142 · Cited by 330
Barrett, E. J., Eggleston, E. M., Inyard, A. C., Wang, H., Li, G., Chai, W., & Liu, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1313-z · Cited by 323
Kandzari, D. E., Bhatt, D. L., Sobotka, P. A., O'Neill, W. W., Esler, M., Flack, J. M., Katzen, B. T., Leon, M. B., Massaro, J. M., Negoita, M., et al. (2012) · Clinical Cardiology · doi:10.1002/clc.22008 · Cited by 310
Obesity Blunts Insulin-Mediated Microvascular Recruitment in Human Forearm Muscle
Clerk, L. H., Vincent, M. A., Jahn, L. A., Liu, Z., Lindner, J. R., & Barrett, E. J. (2006) · Diabetes · doi:10.2337/db05-1373 · Cited by 300
“However, systemically administered insulin is known to increase plasma catecholamines (29,30) and cardiac output.”
BackgroundVollenweider, P., Randin, D., Tappy, L., Jéquier, E., Nicod, P., & Scherrer, U. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117242 · Cited by 285
Self-citationInsulin-induced vasodilatation: physiology or pharmacology?
Yki-Järvinen, H., & Utriainen, T. (1998) · Diabetologia · doi:10.1007/s001250050919 · Cited by 261
Sympathetic system activity in obesity and metabolic syndrome
TENTOLOURIS, N., LIATIS, S., & KATSILAMBROS, N. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.010 · Cited by 260
Fructose ingestion acutely elevates blood pressure in healthy young humans
Brown, C. M., Dulloo, A. G., Yepuri, G., & Montani, J.-P. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00680.2007 · Cited by 242
“The relative lack of an insulin response after fructose (8, 11, 12, 15, 28, 32, 37) might, at least in part, explain the absence of peripheral vasodilatation.”
BackgroundResultInfluentialObesity and adipokines: effects on sympathetic overactivity
Smith, M. M., & Minson, C. T. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.221036 · Cited by 237
“…(Fagius & Berne, 1994; Cox et al. 1995; Young et al. 2010) or during a hyperinsulinaemic euglycaemic clamp (Anderson et al. 1991; Berne et al. 1992; Vollenweider et al. 1993; Hausberg et al. 1995; Van De Borne et al. 1999) increases MSNA and enhances the arterial baroreflex gain of sympathetic…”
BackgroundDuplain, H., Vollenweider, L., Delabays, A., Nicod, P., Bärtsch, P., & Scherrer, U. (1999) · Circulation · doi:10.1161/01.cir.99.13.1713 · Cited by 231
Self-citationThermic effect of food and sympathetic nervous system activity in humans
Tappy, L. (1996) · Reproduction Nutrition Development · doi:10.1051/rnd:19960405 · Cited by 177
“Second, it was noted that the decreased TEF of obese patients was observed after glucose feeding but not after fructose (Simonson et al, 1988) or amino acid administration (Tappy et al, 1993).”
BackgroundSelf-citationObesity-Related Metabolic Syndrome: Mechanisms of Sympathetic Overactivity
Canale, M. P., Manca di Villahermosa, S., Martino, G., Rovella, V., Noce, A., De Lorenzo, A., & Di Daniele, N. (2013) · International Journal of Endocrinology · doi:10.1155/2013/865965 · Cited by 218
“Insulin resistance Direct antinatriuretic action (i) Its intracerebral administration increases sympathetic outflow (ii) Induces sympathetic overactivity (iii) Stimulates SNS to increase cardiac output [46–50] [39, 49, 56– 58]”
BackgroundHuggett, R. J., Burns, J., Mackintosh, A. F., & Mary, D. A. S. G. (2004) · Hypertension · doi:10.1161/01.hyp.0000147893.08533.d8 · Cited by 211
Taddei, S., Virdis, A., Mattei, P., Natali, A., Ferrannini, E., & Salvetti, A. (1995) · Circulation · doi:10.1161/01.cir.92.10.2911 · Cited by 185
Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology
Sowers, J. R. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.691 · Cited by 186
Hormonal modulation of endothelial NO production
Duckles, S. P., & Miller, V. M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0797-1 · Cited by 175
“The ability of insulin to cause vasodilatation is not merely a consequence of changes in carbohydrate metabolism [97].”
Suppression of Alcohol-Induced Hypertension by Dexamethasone
Randin, D., Vollenweider, P., Tappy, L., Jéquier, E., Nicod, P., & Scherrer, U. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322601 · Cited by 177
Self-citationInsulin resistance and the sympathetic nervous system
Egan, B. M. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0028-7 · Cited by 169
“In other studies, Wollenweider et al. [ 53 ] found that MSNA in 37 healthy subjects correlated most strongly with BMI (r = 0.67, P < 0.001) and total body fat (r = 0.64, P < 0.001) and less strongly with plasma insulin (r = 0.34, P < 0.04).”
BackgroundInfluentialThe sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?
Lansdown, A., & Rees, D. A. (2012) · Clinical Endocrinology · doi:10.1111/cen.12003 · Cited by 165
ROLE OF BLOOD FLOW IN THE REGULATION OF MUSCLEGLUCOSE UPTAKE
Baron, A. D., & Clark, M. G. (1997) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.17.1.487 · Cited by 157
Nuutila, P., Raitakari, M., Laine, H., Kirvelä, O., Takala, T., Utriainen, T., Mäkimattila, S., Pitkänen, O. P., Ruotsalainen, U., Iida, H., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118601 · Cited by 157
“(52) observed an z 15% increase in blood flow at 45 min, Anderson et al.”
BackgroundUtriainen, T., Malmstr�m, R., M�kimattila, S., & Yki-J�rvinen, H. (1995) · Diabetologia · doi:10.1007/bf00400724 · Cited by 158
“In contrast to the marked [2, 3, 6, 7] increases in blood flow in the studies performed using the thermodilution technique, no increase [8-14] or a less marked increase [ 15-19 ] in the blood flow response 556”
ResultJordan, J., Yumuk, V., Schlaich, M., Nilsson, P. M., Zahorska-Markiewicz, B., Grassi, G., Schmieder, R. E., Engeli, S., & Finer, N. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283537347 · Cited by 154
“Hyperinsulinemia may also promote neurohumoral activation [19].”
Mechanisms of dexamethasone-induced insulin resistance in healthy humans
Tappy, L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.4.1063 · Cited by 166
Self-citationRichards, O. C., Raines, S. M., & Attie, A. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0035 · Cited by 160
Neurogenic Abnormalities in Masked Hypertension
Grassi, G., Seravalle, G., Trevano, F. Q., Dell’Oro, R., Bolla, G., Cuspidi, C., Arenare, F., & Mancia, G. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.092528 · Cited by 141
Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System
Tsioufis, C., Kordalis, A., Flessas, D., Anastasopoulos, I., Tsiachris, D., Papademetriou, V., & Stefanadis, C. (2011) · International Journal of Hypertension · doi:10.4061/2011/642416 · Cited by 139
“Findings of increased MSNA after infusion of insulin in humans could suggest a triggering role of insulin for the SNS [30].”
BackgroundSugary drinks in the pathogenesis of obesity and cardiovascular diseases
Brown, C. M., Dulloo, A. G., & Montani, J.-P. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.204 · Cited by 161
Mechanisms of Insulin Action on Sympathetic Nerve Activity
Muntzel, M. S., Anderson, E. A., Johnson, A. K., & Mark, A. L. (1995) · Clinical and Experimental Hypertension · doi:10.3109/10641969509087053 · Cited by 136
“Acuteadministration of physiolo_c concentrations ofinsulininnormotensivehumanselevatedsympathetic activity withoutincreasingarterialpressure,in fact,short-terminsulinadministration typicallyproducedacomplexpatternof responses, consistingof increased sympathetic nerveactivity,elevatedheartrate,skeletal musclevasodilati…”
BackgroundInfluentialWesterbacka, J., Wilkinson, I., Cockcroft, J., Utriainen, T., Vehkavaara, S., & Yki-Järvinen, H. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1118 · Cited by 136
Valensi, P. E. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01356-w · Cited by 165
“Besides, in case of insulin resistance, a vascular resistance to the vasodilative effect of insulin is also observed promoting development of hypertension [64].”
BackgroundMilk Products, Insulin Resistance Syndrome and Type 2 Diabetes
Tremblay, A., & Gilbert, J.-A. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719809 · Cited by 123
“This is concordant with the documented stimulating effect of insulin on sympathetic nervous system activity [49–51].”
ResultScherrer, U., & Sartori, C. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420315 · Cited by 118
Self-citationRapid Onset of Renal Sympathetic Nerve Activation in Rabbits Fed a High-Fat Diet
Armitage, J. A., Burke, S. L., Prior, L. J., Barzel, B., Eikelis, N., Lim, K., & Head, G. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190413 · Cited by 115
“is associated with elevated sympathetic activity in skeletal muscle.(24) The relationship among insulin, leptin, and MAP appears more complex than we have reported previously,(9) because the rising trend of MAP follows that of insulin and leptin during the onset of obesity but does not appear to hold after the withdra…”
BackgroundMagnan, C., Collins, S., Berthault, M.-F., Kassis, N., Vincent, M., Gilbert, M., Pénicaud, L., Ktorza, A., & Assimacopoulos-Jeannet, F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3883 · Cited by 115
Straznicky, N. E., Lambert, G. W., Masuo, K., Dawood, T., Eikelis, N., Nestel, P. J., McGrane, M. T., Mariani, J. A., Socratous, F., Chopra, R., et al. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26299 · Cited by 115
Perturbed Autonomic Nervous System Function in Metabolic Syndrome
Tentolouris, N., Argyrakopoulou, G., & Katsilambros, N. L. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8022-5 · Cited by 140
OBESITY AND AUTONOMIC FUNCTION IN ADOLESCENCE
Riva, P., Martini, G., Rabbia, F., Milan, A., Paglieri, C., Chiandussi, L., & Veglio, F. (2001) · Clinical and Experimental Hypertension · doi:10.1081/ceh-100001197 · Cited by 107
“It has been also shown that sympathetic activation is related primarily to hyperinsulinemia itself, rather than to stimulation of carbohydrate metabolism (47).”
BackgroundSartori, C. S., Lepori, M., & Scherrer, U. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.009 · Cited by 108
Self-citationOwlya, R., Vollenweider, L., Trueb, L., Sartori, C., Lepori, M., Nicod, P., & Scherrer, U. (1997) · Circulation · doi:10.1161/01.cir.96.11.3897 · Cited by 106
Self-citationINSULIN AS A VASCULAR HORMONE: IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF CARDIOVASCULAR DISEASE
Cleland, S. J., Petrie, J. R., Ueda, S., Elliott, H. L., & Connell, J. M. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.t01-15-.x · Cited by 102
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome
Seravalle, G., & Grassi, G. M. (2016) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0137-4 · Cited by 111
“While muscle sympathetic nerve activity is increased following acute hyperinsulinemia [27, 28], renal norepinephrine spillover remains unchanged [28] and no association has been observed between hyperinsulinemia and the rate of renal norepinephrine spillover to plasma in obese [21].”
BackgroundDoucet, E., St. Pierre, S., Alméras, N., Mauriège, P., Richard, D., & Tremblay, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6500 · Cited by 92
Circulating Endothelin-1 Levels Increase During Euglycemic, Hyperinsulinemic Clamp in Lean NIDDM Men
Ferri, C., Carlomagno, A., Coassin, S., Baldoncini, R., Faldetta, M. R. C., Laurenti, O., Properzi, G., Santucci, A., & Mattia, G. D. (1995) · Diabetes Care · doi:10.2337/diacare.18.2.226 · Cited by 92
“Hyperinsulinemia could promote vascular damage (6) through increased platelet (8), sympathetic nervous system (9,10), Na/Li countertransport (11), and Na/H antiport activities (11-13).”
BackgroundCarotid body, insulin, and metabolic diseases: unraveling the links
Conde, S. V., Sacramento, J. F., Guarino, M. P., Gonzalez, C., Obeso, A., Diogo, L. N., Monteiro, E. C., & Ribeiro, M. J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00418 · Cited by 87
“The MSNA response observed in response to insulin administration is both gradual (Anderson et al., 1991; Scherrer et al., 1993; Vollenweider et al., 1993, 1994; Banks, 2004) and sustained because MSNA remains increased even after plasma insulin levels return to baseline (Anderson et al., 1991;…”
BackgroundInfluentialHemodynamic and Renal Responses to Chronic Hyperinsulinemia in Obese, Insulin-Resistant Dogs
Hall, J. E., Brands, M. W., Zappe, D. H., Dixon, W. N., Mizelle, H. L., Reinhart, G. A., & Hildebrandt, D. A. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.994 · Cited by 84
Rosen, P., Ohly, P., & Gleichmann, H. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715011-00004 · Cited by 82
Fryburg, D. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118548 · Cited by 82
“, activation of the sympathetic nervous system (43, 46, 47).”
BackgroundEffects of insulin on adipose tissue blood flow in man
Karpe, F., Fielding, B. A., Ardilouze, J., Ilic, V., Macdonald, I. A., & Frayn, K. N. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013358 · Cited by 81
Labayen, I., Forga, L., & Martínez, J. A. (1999) · European Journal of Nutrition · doi:10.1007/s003940050057 · Cited by 91
“This effect has been attributed in several studies (17, 43, 50 ) to a central action of insulin on hypothalamic areas, and other investigators (14, 51, 52) reported that is some aspect of cellular metabolism, and not insulin per se, that is responsible for activation of the sympathetic nervous system.”
Insulin Resistance and Hypertension in Japanese
Iimura, O. (1996) · Hypertension Research · doi:10.1291/hypres.19.supplementi_s1 · Cited by 81
“(66-68) and/or the renin-angiotensin system (69, 70) and lead to an increase in blood pressure.”
BackgroundSympathetic nerve activity in metabolic control – some basic concepts
Fagius, J. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01086.x · Cited by 78
Sympathetic dysregulation in heart failure: Mechanisms and therapy
Mark, A. Y. L. (1995) · Clinical Cardiology · doi:10.1002/clc.4960181303 · Cited by 75
Monroe, M., Pelt, R. E. V., Schiller, B. C., Seals, D. R., & Jones, P. P. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801364 · Cited by 81
Utriainen, T., Nuutila, P., Takala, T., Vicini, P., Ruotsalainen, U., Rönnemaa, T., Tolvanen, T., Raitakari, M., Haaparanta‐Solin, M., Kirvelä, O., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119591 · Cited by 84
“First, previous studies have shown that insulin rather than the rate of glucose metabolism determines the magnitude of insulin-induced vasodilation (14, 68).”
BackgroundSeematter, G., Guenat, E., Schneiter, P., Cayeux, C., Jéquier, E., & Tappy, L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e799 · Cited by 74
Self-citationInsulin-Mediated Vasodilation and Glucose Uptake Are Functionally Linked in Humans
Cleland, S. J., Petrie, J. R., Ueda, S., Elliott, H. L., & Connell, J. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.554 · Cited by 82
de Jongh, R. T., Clark, A. D. H., IJzerman, R. G., Serné, E. H., de Vries, G., & Stehouwer, C. D. A. (2004) · Diabetologia · doi:10.1007/s00125-004-1412-9 · Cited by 71
“In our study, as in many previous studies, insulin increased total leg blood flow [8, 17, 26].”
ResultDose-Dependent Vasodilating Effects of Insulin on Adenosine-Stimulated Myocardial Blood Flow
Sundell, J., Nuutila, P., Laine, H. K., Luotolahti, M., Kalliokoski, K. K., Raitakari, O. T., & Knuuti, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1125 · Cited by 70
Murton, A. J. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665115000130 · Cited by 66
“The administration of insulin to produce physiological hyperinsulinaemia has been repeatedly shown to stimulate enhanced blood flow to muscle tissue((12,34,35)) and therefore, the incretin effect of food consumption acts to prime the system to assist in the delivery of glucose and amino acids to peripheral tissues.”
BackgroundSartori, C. S., & Scherrer, U. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917110-00003 · Cited by 74
Self-citationLandsberg, L., Young, J. B., Leonard, W. R., Linsenmeier, R. A., & Turek, F. W. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.017 · Cited by 69
Insulin/adenosine axis linked signalling
Silva, L., Subiabre, M., Henríquez, J. A., Sáez, T., Salsoso, R., Pardo, F., Leiva, A., Martín, R. S., Toledo, F., & Sobrevía, L. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.11.002 · Cited by 65
Rafiq, K., Fujisawa, Y., Sherajee, S. J., Rahman, A., Sufiun, A., Kobori, H., Koepsell, H., Mogi, M., Horiuchi, M., & Nishiyama, A. (2015) · Diabetologia · doi:10.1007/s00125-015-3771-9 · Cited by 65
“Obese and diabetic patients show an increase in renal sympathetic nerve activity, which is associated with hypertension, insulin resistance and cardio-renal syndrome [6, 8, 9].”
Insulin-mediated increase in blood flow is impaired in the elderly
Meneilly, G. S. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1899 · Cited by 68
Doucet, É., St‐Pierre, S., Alméras, N., Mauriège, P., Després, J., Richard, D., Bouchard, C., & Tremblay, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6980 · Cited by 84
“In this sense, Vollenweider et al. ( 5 ) have shown that during a euglycemic-hyperinsulinemic clamp the increase in insulin was associated with an increase in sympathetic nervous system (SNS) activity, which is also in accordance with the results of Berne et al. (6).”
ResultDoucet, E., Imbeault, P., Alméras, N., & Tremblay, A. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00415.x · Cited by 62
Glucose ingestion affects cardiac ANS in healthy subjects with different amounts of body fat.
Paolisso, G., Manzella, D., Ferrara, N., Gambardella, A., Abete, P., Tagliamonte, M. R., De Lucia, D., Furgi, G., Picone, C., Gentile, S., et al. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.3.e471 · Cited by 61
McKay, M. K., & Hester, R. L. (1996) · Hypertension · doi:10.1161/01.hyp.28.2.202 · Cited by 60
Esler, M., Lambert, G., Schlaich, M., Dixon, J., Sari, C. I., & Lambert, E. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.09790 · Cited by 60
SCOTT, E. M., Greenwood, J. P., Vacca, G., Stoker, J. B., Gilbey, S. G., & Mary, D. (2002) · Clinical Science · doi:10.1042/cs1020523 · Cited by 67
Myocardial Blood Flow and Glucose Metabolism in Diabetes Mellitus
Meyer, C., & Schwaiger, M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00463-3 · Cited by 64
Rafeh, R. W., Viveiros, A., Oudit, G. Y., & EL‐Yazbi, A. F. (2020) · Clinical Science · doi:10.1042/cs20190227 · Cited by 66
The edematogenic properties of insulin
Kalambokis, G. N., Tsatsoulis, A. A., & Tsianos, E. V. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.06.025 · Cited by 74
Weissman, A., Lowenstein, L., Peleg, A., Thaler, I., & Zimmer, E. Z. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-2009 · Cited by 57
Tappy, L., Berger, M. M., Schwarz, J., Schneiter, P., Kim, S., Revelly, J., & Chioléro, R. L. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.03.008 · Cited by 64
Self-citationDisparity of autonomic control in type 2 diabetes mellitus
Huggett, R. J., SCOTT, E. M., Gilbey, S. G., Bannister, J., Mackintosh, A., & Mary, D. A. S. G. (2004) · Diabetologia · doi:10.1007/s00125-004-1601-6 · Cited by 62
“Extensive research shows that in normal healthy individuals acute hyperinsulinaemia in itself increases resting sympathetic output [1].”
BackgroundInsights Into the Pathogenesis and Prevention of Coronary Artery Disease
O’Keefe, J. H., Lavie, C. J., & McCallister, B. D. (1995) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64669-7 · Cited by 61
Frontoni, S., Bracaglia, D., Baroni, A., Pellegrini, F., Perna, M., Cicconetti, E., Ciampittiello, G., Menzinger, G., & Gambardella, S. (2003) · Hypertension · doi:10.1161/01.hyp.0000073062.29546.01 · Cited by 56
Trovati, M., Massucco, P., Mattiello, L., Cavalot, F. L., Mularoni, E., Hahn, A., & Anfossi, G. (1995) · Diabetologia · doi:10.1007/bf00400582 · Cited by 57
Utriainen, T., Mäkimattila, S., Virkamäki, A., Bergholm, R., & Yki‐Järvinen, H. (1996) · Diabetologia · doi:10.1007/s001250050601 · Cited by 59
“In contrast, the effects on limb blood flow are controversial, some studies showing no or marginal increases [2, 36, 38–40], while others have found significant increases (20–60%) [3, 41, 42] during this time period.”
ResultBisquolo, V. A. F., Cardoso, C. G., Ortega, K. C., Gusmão, J. L., Tinucci, T., Negrão, C. E., Wajchenberg, B. L., Mion, D., & Forjaz, C. L. M. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00251.2004 · Cited by 54
“However, it is interesting that acute insulin infusion does not always result in blood pressure (BP) increase (5, 38, 39).”
Background
Metadata
- Authors
- Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Venue
- Journal of Clinical Investigation
- Published
- 1993-07-01
- Volume
- 92
- Issue
- 1
- Pages
- 147-154
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC293552
- OpenAlex
- W2126021651
- Cited by
- 321
- References
- 55
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 11 · 2016: 12 · 2015: 7 · 2014: 9 · 2013: 12 · 2012: 15
- FWCI
- 47.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (28668)
- Nestec
- Topics
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- hyperinsulinemia, euglycemic clamp, muscle sympathetic nerve activity, skeletal muscle blood flow, carbohydrate metabolism, fructose infusion, glucose infusion, insulin, vasodilation, carbohydrate oxidation, energy expenditure
- MeSH terms
- Adult, Blood Glucose, Calorimetry, Catecholamines, Energy Metabolism, Fructose, Humans, Insulin, Muscles, Potassium, Regional Blood Flow, Sympathetic Nervous System, Vascular Resistance, Carbohydrate Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.